CURRENT AFFAIRS

2023

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
Which country is set to manufacture generic variant of long-acting cabotegravir (CAB-LA) drug, used for HIV prevention?
A
India
B
USA
C
South Africa
D
Israel
Explanation: 

Detailed explanation-1: -The Indian drug company Cipla confirmed that a generic version of the prophylaxis, long-acting cabotegravir (CAB-LA), would be manufactured at its plants in Benoni, near Johannesburg, or Durban.

Detailed explanation-2: -Well, this medication is a Human Immunodeficiency Virus (HIV) anti-retroviral (ARV) that has been recently approved by the South African Health Products Regulatory Authority (SAHPRA). What is CAB-LA?

Detailed explanation-3: -Cabotegravir comes in the following forms and strengths: 30-mg tablets (brand name: Vocabria) 600 mg/3 mL single-dose vials of extended-release injectable suspension (brand name: Apretude)

Detailed explanation-4: -CAB is a single antiretroviral drug given as an intramuscular injection every 2 months to prevent HIV. In 2021, the US Preventive Services Task Force issued a graded recommendation to prescribe CAB for PrEP to adult patients who are at risk of getting HIV through sex (grade IA).

There is 1 question to complete.